IncellDx, a company that's marketing a diagnostic and treatment plan for long COVID, says it's not at all associated with the Front Line COVID-19 Critical Care Alliance (FLCCC) after being listed on ...
Bio-Reference Laboratories Inc., a publicly traded company, has invested an undisclosed amount in InCellDx Inc., a molecular diagnostics start-up. Details of the round were not released. Bio-Reference ...
CARLSBAD, Calif., March 21, 2018 /PRNewswire/ -- GIMDx, Inc. ("GIMDx") a US subsidiary of Guangzhou Improve Medical Instruments Co., Ltd., announces accelerated commercialization of IncellDx, Inc.'s ( ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--IncellDx today announced it has been granted U.S. Patent No. 11,180, 491 by the U.S. Patent and Trademark Office (“USPTO”) for methods of treating coronaviruses ...
IncellDx’s Chronic COVID Treatment Center (CCTC) (www.covidlonghaulers.com) and ARISE™ MD Integrative Medicine & Surgery announced today a new partnership to evaluate CCR5 antagonists and statins as a ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--IncellDx, a precision medicine company advancing novel diagnostics and prognostics to better understand and treat infectious disease and cancer, today announced ...
SAN CARLOS, Calif., Sept. 24, 2020 /PRNewswire/ -- IncellDx, Inc., a global leader in single-cell diagnostics, announces the USPTO has issued patent US10,782,298 to IncellDx. This patent covers a ...
Frost & Sullivan (F&S), an international management consultancy that identifies best practices in research, will present IncellDx with a Leadership Award in the Molecular Diagnostics Market. F&S cited ...
SAN CARLOS, Calif. — IncellDx, Inc., a global leader in single-cell diagnostics, announces approval by the Costa Rican Ministry of Health of its Next Generation HPV/cervical cancer assay, OncoTect 3Dx ...
The precision diagnostics leader and molecular diagnostics company are joining forces to develop new, innovative testing for urogenital cancers that will improve the standard of care. Dr. John Feller, ...
IncellDx’s HPV OncoTect ® E6/E7 mRNA Kit Greatly Increases Specificity Compared to Other HPV tests and was Successfully Used in a Large Clinical Trial in Women Under 30 Years of Age. MENLO PARK, Calif ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results